Literature DB >> 1488087

An immunohistochemical study of mononuclear cells in meningiomas.

L Bø1, S J Mørk, H Nyland.   

Abstract

A consecutive series of 34 meningiomas were re-examined as to subtype and presence of nuclear atypia, mitotic figures, areas of high cellularity and necrosis. Meningioma cells were epithelial membrane antigen (EMA) positive in 31 out of the 34 tumours. The presence of mononuclear cells and macrophages was assessed by immunohistochemistry using the monoclonal antibodies L26 (CD20, B cell marker), DF-T1 (CD43, T cell marker), KP1 (CD68, macrophage marker) and MAC387 (monocytes). L26 positive B cells were observed infrequently. CD43 positive mononuclear cells were infiltrating the parenchyma as individual cells and as groups of cells in 29 (87% of the tumours). CD68 positive macrophages were seen in 19 (59% of the tumours), as scattered single cells or groups of cells. There was a statistically significant association between the number of CD68 positive cells (necrotic areas excluded) and microscopic features of aggressiveness, i.e. high cellularity as well as the combination of nuclear atypia and frequent mitotic figures. MAC387 stained only a few cells; the immunopositive cells were present mainly within and around vessels. Meningioma cells displayed a diffuse immunopositivity for L26 (CD20) in 29 out of 34 meningiomas, but did not stain with macrophage markers. Mast cells were found in 9 out of 32 tumours; when present they were significantly more prevalent in the syncytial subtype. Thus, mononuclear cell infiltrates in meningiomas are mainly composed of T cells and macrophages, indicating an immune system surveillance and response to the tumour cells. The functional and prognostic significance of the presence of CD68 positive cells, macrophages, deserve further study in the search for more reliable histological criteria to predict recurrence and biological aggressiveness in meningiomas.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1488087     DOI: 10.1111/j.1365-2990.1992.tb00825.x

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


  15 in total

1.  Chordoid meningioma, an uncommon variant of meningioma: a clinicopathologic study of 12 cases.

Authors:  S Epari; M C Sharma; C Sarkar; A Garg; A Gupta; V S Mehta
Journal:  J Neurooncol       Date:  2006-04-21       Impact factor: 4.130

2.  Ferumoxytol-enhanced MRI differentiation of meningioma from dural metastases: a pilot study with immunohistochemical observations.

Authors:  Bronwyn E Hamilton; Randall L Woltjer; Joao Prola-Netto; Gary M Nesbit; Seymur Gahramanov; Thao Pham; Jaime Wagner; Edward A Neuwelt
Journal:  J Neurooncol       Date:  2016-07-08       Impact factor: 4.130

Review 3.  Pathogenesis of peri-tumoral edema in intracranial meningiomas.

Authors:  Moncef Berhouma; Timothee Jacquesson; Emmanuel Jouanneau; François Cotton
Journal:  Neurosurg Rev       Date:  2017-08-24       Impact factor: 3.042

4.  Secretory meningioma: immunohistochemical findings and evaluation of mast cell infiltration.

Authors:  Wuttipong Tirakotai; Hans-Dieter Mennel; Ilhan Celik; Dieter Hellwig; Helmut Bertalanffy; Thomas Riegel
Journal:  Neurosurg Rev       Date:  2005-07-12       Impact factor: 3.042

5.  The histopathological spectrum of human meningiomas.

Authors:  Thomas Backer-Grøndahl; Bjørnar H Moen; Sverre H Torp
Journal:  Int J Clin Exp Pathol       Date:  2012-03-25

6.  Increased proliferative activity due to necroses induced by pre-operative embolization in benign meningiomas.

Authors:  E Patsouris; R Laas; C Hagel; D Stavrou
Journal:  J Neurooncol       Date:  1998-12       Impact factor: 4.130

7.  Mast cell and macrophage counts and microvessel density in invasive breast carcinoma-comparison analysis with clinicopathological parameters.

Authors:  Gui Young Kwon; Sang Dae Lee; Eon Sub Park
Journal:  Cancer Res Treat       Date:  2005-04-30       Impact factor: 4.679

8.  Immunosuppressive activity of tumor-infiltrating myeloid cells in patients with meningioma.

Authors:  Laura Pinton; Samantha Solito; Elena Masetto; Marina Vettore; Stefania Canè; Alessandro Della Puppa; Susanna Mandruzzato
Journal:  Oncoimmunology       Date:  2018-03-15       Impact factor: 8.110

9.  An experimental model of leptomeningeal metastases employing rat mammary carcinoma cells.

Authors:  S M Sagar; K J Price
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

10.  The immune cell infiltrate populating meningiomas is composed of mature, antigen-experienced T and B cells.

Authors:  Liangjuan Fang; Daniel E Lowther; Matthew L Meizlish; Richard C E Anderson; Jeffrey N Bruce; Lesley Devine; Anita J Huttner; Steven H Kleinstein; Jae-Yun Lee; Joel N H Stern; Gur Yaari; Laura Lovato; Katharine M Cronk; Kevin C O'Connor
Journal:  Neuro Oncol       Date:  2013-08-26       Impact factor: 12.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.